PMID- 17012607 OWN - NLM STAT- MEDLINE DCOM- 20070212 LR - 20161124 IS - 0022-3565 (Print) IS - 0022-3565 (Linking) VI - 320 IP - 1 DP - 2007 Jan TI - Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. PG - 274-80 AB - Thyroid hormone (TH) plays a fundamental role in thermoregulation, yet the molecular mediators of its effects are not fully defined. Recently, skeletal muscle (SKM) uncoupling protein (UCP) 3 was shown to be an important mediator of the thermogenic effects of the widely abused sympathomimetic agents 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) and methamphetamine. Expression of UCP3 is regulated by TH. Activation of UCP3 is indirectly regulated by norepinephrine (NE) and is dependent upon the availability of free fatty acids (FFAs). We hypothesized that UCP3 may be a molecular link between TH and hyperthermia, requiring increased levels of both NE and FFAs to accomplish the thermogenic effect. Here, we demonstrate that MDMA (40 mg/kg s.c.) significantly increases plasma FFA levels 30 min after treatment. Pharmacologically increasing NE levels through the inhibition of phenylethanolamine N-methyltransferase with +/-2,3-dichloro-alpha-methylbenzylamine potentiated the hyperthermic effects of a 20 mg/kg dose of MDMA. Using Western blots and regression analysis, we further illustrated that chronic hyperthyroidism in rats potentiates the hyperthermic effects of MDMA and increases levels of SKM UCP3 protein in a linear fashion according to levels of circulating plasma TH. Conversely, chronic hypothyroidism results in a hypothermic response to MDMA that is directly proportionate to decreased UCP3 expression. Acute TH supplementation did not change the skeletal muscle UCP3 expression levels or temperature responses to MDMA. These findings suggest that, although MDMA-induced hyperthermia appears to result from increased NE and FFA levels, susceptibility is ultimately determined by TH regulation of UCP3-dependent thermogenesis. FAU - Sprague, Jon E AU - Sprague JE AD - The Department of Pharmaceutical and Biomedical Sciences, The Raabe College of Pharmacy, Ohio Northern University, Ada, Ohio, USA. FAU - Yang, Xianmei AU - Yang X FAU - Sommers, Joni AU - Sommers J FAU - Gilman, Tracy L AU - Gilman TL FAU - Mills, Edward M AU - Mills EM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060929 PL - United States TA - J Pharmacol Exp Ther JT - The Journal of pharmacology and experimental therapeutics JID - 0376362 RN - 0 (Fatty Acids, Nonesterified) RN - 0 (Ion Channels) RN - 0 (Mitochondrial Proteins) RN - 0 (Sympathomimetics) RN - 0 (Ucp3 protein, rat) RN - 0 (Uncoupling Protein 3) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - Q51BO43MG4 (Thyroxine) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - Animals MH - Fatty Acids, Nonesterified/*blood MH - Ion Channels/*analysis MH - Male MH - Mitochondrial Proteins/*analysis MH - Muscle, Skeletal/*chemistry MH - N-Methyl-3,4-methylenedioxyamphetamine/pharmacology MH - Norepinephrine/*physiology MH - Rats MH - Rats, Sprague-Dawley MH - Sympathomimetics/*pharmacology MH - Thermogenesis/*drug effects MH - Thyroid Gland/*physiology MH - Thyroxine/blood MH - Uncoupling Protein 3 EDAT- 2006/10/03 09:00 MHDA- 2007/02/13 09:00 CRDT- 2006/10/03 09:00 PHST- 2006/10/03 09:00 [pubmed] PHST- 2007/02/13 09:00 [medline] PHST- 2006/10/03 09:00 [entrez] AID - jpet.106.107755 [pii] AID - 10.1124/jpet.106.107755 [doi] PST - ppublish SO - J Pharmacol Exp Ther. 2007 Jan;320(1):274-80. doi: 10.1124/jpet.106.107755. Epub 2006 Sep 29.